BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

635 related articles for article (PubMed ID: 27867017)

  • 21. Taselisib (GDC-0032), a Potent β-Sparing Small Molecule Inhibitor of PI3K, Radiosensitizes Head and Neck Squamous Carcinomas Containing Activating PIK3CA Alterations.
    Zumsteg ZS; Morse N; Krigsfeld G; Gupta G; Higginson DS; Lee NY; Morris L; Ganly I; Shiao SL; Powell SN; Chung CH; Scaltriti M; Baselga J
    Clin Cancer Res; 2016 Apr; 22(8):2009-19. PubMed ID: 26589432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SOX4 expression is associated with treatment failure and chemoradioresistance in oral squamous cell carcinoma.
    Yoon TM; Kim SA; Cho WS; Lee DH; Lee JK; Park YL; Lee KH; Lee JH; Kweon SS; Chung IJ; Lim SC; Joo YE
    BMC Cancer; 2015 Nov; 15():888. PubMed ID: 26555193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The FA/BRCA Pathway Identified as the Major Predictor of Cisplatin Response in Head and Neck Cancer by Functional Genomics.
    Martens-de Kemp SR; Brink A; van der Meulen IH; de Menezes RX; Te Beest DE; Leemans CR; van Beusechem VW; Braakhuis BJ; Brakenhoff RH
    Mol Cancer Ther; 2017 Mar; 16(3):540-550. PubMed ID: 27980104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Upregulation of the long non-coding RNA CASC9 as a biomarker for squamous cell carcinoma.
    Sassenberg M; Droop J; Schulz WA; Dietrich D; Loick SM; Wiek C; Scheckenbach K; Gaisa NT; Hoffmann MJ
    BMC Cancer; 2019 Aug; 19(1):806. PubMed ID: 31412811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RPA3 is a potential marker of prognosis and radioresistance for nasopharyngeal carcinoma.
    Qu C; Zhao Y; Feng G; Chen C; Tao Y; Zhou S; Liu S; Chang H; Zeng M; Xia Y
    J Cell Mol Med; 2017 Nov; 21(11):2872-2883. PubMed ID: 28557284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oct4 confers stemness and radioresistance to head and neck squamous cell carcinoma by regulating the homologous recombination factors PSMC3IP and RAD54L.
    Nathansen J; Lukiyanchuk V; Hein L; Stolte MI; Borgmann K; Löck S; Kurth I; Baumann M; Krause M; Linge A; Dubrovska A
    Oncogene; 2021 Jun; 40(24):4214-4228. PubMed ID: 34079088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The NEDD8 conjugation pathway regulates p53 transcriptional activity and head and neck cancer cell sensitivity to ionizing radiation.
    Guihard S; Ramolu L; Macabre C; Wasylyk B; Noël G; Abecassis J; Jung AC
    Int J Oncol; 2012 Oct; 41(4):1531-40. PubMed ID: 22895816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma.
    Lv Z; Wu X; Cao W; Shen Z; Wang L; Xie F; Zhang J; Ji T; Yan M; Chen W
    J Exp Clin Cancer Res; 2014 Dec; 33(1):100. PubMed ID: 25539663
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of SESN1, UHRF1BP1, and miR-377-3p as prognostic markers in mutated TP53 squamous cell carcinoma of the head and neck.
    El Baroudi M; Machiels JP; Schmitz S
    Cancer Biol Ther; 2017 Oct; 18(10):775-782. PubMed ID: 28886272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel panel of biomarkers predicts radioresistance in patients with squamous cell carcinoma of the head and neck.
    Akervall J; Nandalur S; Zhang J; Qian CN; Goldstein N; Gyllerup P; Gardinger Y; Alm J; Lorenc K; Nilsson K; Resau J; Wilson G; Teh B
    Eur J Cancer; 2014 Feb; 50(3):570-81. PubMed ID: 24332450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The fanconi anemia pathway limits human papillomavirus replication.
    Hoskins EE; Morreale RJ; Werner SP; Higginbotham JM; Laimins LA; Lambert PF; Brown DR; Gillison ML; Nuovo GJ; Witte DP; Kim MO; Davies SM; Mehta PA; Butsch Kovacic M; Wikenheiser-Brokamp KA; Wells SI
    J Virol; 2012 Aug; 86(15):8131-8. PubMed ID: 22623785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low cytoplasmic and nuclear KPNA2 expression in radiotherapy-treated head and neck squamous cell cancer is associated with an adverse outcome.
    Erben PB; Brunner K; Hecht M; Haderlein M; Büttner-Herold M; Agaimy A; Fietkau R; Hartmann A; Distel LV
    Int J Clin Exp Pathol; 2015; 8(12):15814-24. PubMed ID: 26884852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Down-regulation of malic enzyme 1 and 2: Sensitizing head and neck squamous cell carcinoma cells to therapy-induced senescence.
    Woo SH; Yang LP; Chuang HC; Fitzgerald A; Lee HY; Pickering C; Myers JN; Skinner HD
    Head Neck; 2016 Apr; 38 Suppl 1():E934-40. PubMed ID: 25994759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV Protease Inhibitors Sensitize Human Head and Neck Squamous Carcinoma Cells to Radiation by Activating Endoplasmic Reticulum Stress.
    Liu R; Zhang L; Yang J; Zhang X; Mikkelsen R; Song S; Zhou H
    PLoS One; 2015; 10(5):e0125928. PubMed ID: 25933118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of excision repair cross-complementation group 1 by Snail contributes to cisplatin resistance in head and neck cancer.
    Hsu DS; Lan HY; Huang CH; Tai SK; Chang SY; Tsai TL; Chang CC; Tzeng CH; Wu KJ; Kao JY; Yang MH
    Clin Cancer Res; 2010 Sep; 16(18):4561-71. PubMed ID: 20823140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicoRNA-451 is a novel tumor suppressor via targeting c-myc in head and neck squamous cell carcinomas.
    Wang H; Zhang G; Wu Z; Lu B; Yuan D; Li X; Lu Z
    J Cancer Res Ther; 2015 Oct; 11 Suppl 2():C216-21. PubMed ID: 26506880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer stem cell related markers of radioresistance in head and neck squamous cell carcinoma.
    Kurth I; Hein L; Mäbert K; Peitzsch C; Koi L; Cojoc M; Kunz-Schughart L; Baumann M; Dubrovska A
    Oncotarget; 2015 Oct; 6(33):34494-509. PubMed ID: 26460734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carbonyl reductase 1 is a new target to improve the effect of radiotherapy on head and neck squamous cell carcinoma.
    Yun M; Choi AJ; Lee YC; Kong M; Sung JY; Kim SS; Eun YG
    J Exp Clin Cancer Res; 2018 Oct; 37(1):264. PubMed ID: 30376862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of DNA methylation and gene expression in radiation-resistant head and neck tumors.
    Chen X; Liu L; Mims J; Punska EC; Williams KE; Zhao W; Arcaro KF; Tsang AW; Zhou X; Furdui CM
    Epigenetics; 2015; 10(6):545-61. PubMed ID: 25961636
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel Pactamycin Analogs Induce p53 Dependent Cell-Cycle Arrest at S-Phase in Human Head and Neck Squamous Cell Carcinoma (HNSCC) Cells.
    Guha G; Lu W; Li S; Liang X; Kulesz-Martin MF; Mahmud T; Indra AK; Ganguli-Indra G
    PLoS One; 2015; 10(5):e0125322. PubMed ID: 25938491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.